High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Past Returns: In past three years, the stock has provided 15.2% return compared to 9.3% by NIFTY 50.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Profitability: Recent profitability of 13% is a good sign.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
No major cons observed.
Valuation | |
|---|---|
| Market Cap | 4.39 kCr |
| Price/Earnings (Trailing) | 16.56 |
| Price/Sales (Trailing) | 2.18 |
| EV/EBITDA | 10.39 |
| Price/Free Cashflow | 92.31 |
| MarketCap/EBT | 12.46 |
| Enterprise Value | 4.38 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 2.01 kCr |
| Rev. Growth (Yr) | -7.6% |
| Earnings (TTM) | 264.97 Cr |
| Earnings Growth (Yr) | -27.3% |
Profitability | |
|---|---|
| Operating Margin | 17% |
| EBT Margin | 17% |
| Return on Equity | 17.17% |
| Return on Assets | 13.06% |
| Free Cashflow Yield | 1.08% |
Growth & Returns | |
|---|---|
| Price Change 1W | 8.3% |
| Price Change 1M | -1.3% |
| Price Change 6M | -34.9% |
| Price Change 1Y | -23.4% |
| 3Y Cumulative Return | 15.2% |
| 5Y Cumulative Return | 5.4% |
| 7Y Cumulative Return | 13.8% |
| 10Y Cumulative Return | 4.6% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -142.72 Cr |
| Cash Flow from Operations (TTM) | 262.66 Cr |
| Cash Flow from Financing (TTM) | -119.88 Cr |
| Cash & Equivalents | 4.08 Cr |
| Free Cash Flow (TTM) | 68.66 Cr |
| Free Cash Flow/Share (TTM) | 15.23 |
Balance Sheet | |
|---|---|
| Total Assets | 2.03 kCr |
| Total Liabilities | 486.2 Cr |
| Shareholder Equity | 1.54 kCr |
| Current Assets | 1.44 kCr |
| Current Liabilities | 437.53 Cr |
| Net PPE | 316.53 Cr |
| Inventory | 478.21 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 73.7 |
| Interest/Cashflow Ops | 52.39 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 2 |
| Dividend Yield | 0.14% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | -3.2% |
Past Returns: In past three years, the stock has provided 15.2% return compared to 9.3% by NIFTY 50.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Profitability: Recent profitability of 13% is a good sign.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
No major cons observed.
Investor Care | |
|---|---|
| Dividend Yield | 0.14% |
| Dividend/Share (TTM) | 2 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 58.77 |
Financial Health | |
|---|---|
| Current Ratio | 3.28 |
| Debt/Equity | 0.00 |
Technical Indicators | |
|---|---|
| RSI (14d) | 45.45 |
| RSI (5d) | 58.86 |
| RSI (21d) | 38.5 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal | Buy |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Dhanuka Agritech's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management at Dhanuka Agritech Limited provided an optimistic outlook for the future, stating that they anticipate recovery from the recent downturn in performance. Mr. M.K. Dhanuka emphasized their commitment to growing revenue and market presence, aiming for a double-digit CAGR over the long term. Significant forward-looking points shared include:
Demand Recovery: The fourth quarter of FY'26 began positively, with January seeing strong sales, particularly for the wheat crop and paddy in South and East India. They expect good harvests for Rabi and Kharif seasons.
Financial Performance: For Q3 FY'26, the revenue from operations was Rs.409.92 crores, down from Rs.445.27 crores in Q3 FY'25, while EBITDA fell to Rs.58.66 crores from Rs.75.56 crores, and net profit decreased to Rs.40 crores from Rs.55.04 crores.
Product Development: The second product from the Dahej plant has been commercialized. Management aims for Dahej operations to become EBITDA positive in FY'27, targeting an 80% capacity utilization.
Net Economic Benefits: The company anticipates a shift in revenue structure as they gain full control over Bayer products, which contributed around Rs.25-27 crores this quarter. Net economic benefits included Rs.19.5 crores over the past nine months.
Market Penetration: Dhanuka plans to enhance penetration into rural markets and expand its distribution channel to reach more farmers, supported by new product introductions.
Ongoing Innovations: Management has been investing in R&D, with collaborations with ten global agrochemical companies to introduce novel technologies in Indian markets.
Regulatory Confidence: The management expressed optimism about upcoming regulatory approvals that could reintroduce previously affected biological products by the end of Q1 FY'27.
Overall, management conveyed confidence in overcoming recent challenges and looked forward to a stronger fiscal year ahead.
Q1: How is the current demand scenario for agrochemicals? What is your expectation from Kharif season?
A1: Q4 has started well; January was good, especially in South and East India. We expect a good harvest of Rabi and are optimistic for Kharif, but we will wait for weather forecasts in late March and early April to finalize our Kharif plans.
Q2: How much is the contribution from technical sales and the Bayer molecules in Q3 and 9 months?
A2: Revenue from Bayer molecules is around Rs.25-27 crores. Technical sales are about Rs.3-4 crores in Q3, and Rs.50 crores over 9 months.
Q3: Can you quantify the negative impact from sales returns?
A3: Sales returns this quarter were Rs.72 crores, slightly lower than last year's Rs.74 crores. Overall, returns have not increased in Q3 compared to the previous year.
Q4: What is the expected revenue from Bayer products next year?
A4: We anticipate a significant drop from Rs.40 crores to approximately Rs.30 crores due to unexpected market conditions affecting grape sales.
Q5: What is the contribution from biologicals in FY'25 and FY'26?
A5: Biologicals contributed less than Rs.2 crores in FY'25, and are nearly negligible in FY'26.
Q6: What is the growth outlook for Dhanuka over the next 3-5 years?
A6: We anticipate double-digit growth, driven by market demand and increased crop cycles. India's current agrochemical consumption is low compared to the global average.
Q7: What risks could prevent achieving this growth?
A7: Besides weather, risks include fluctuating commodity prices and regulatory changes which could influence farmers' input spending and overall agricultural performance.
Q8: What is the current cash on the books?
A8: We have over Rs.250 crores in cash and liquid investments.
Q9: How much CAPEX is expected for the MPP-2 plant?
A9: We expect a CAPEX of Rs.60 to Rs.70 crores for the MPP-2 plant.
Understand Dhanuka Agritech ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| TRIVENI TRUST (Mahendra Kumar Dhanuka) | 57.14% |
| PUSHPA DHANUKA TRUST (Late Arun Kumar Dhanuka) | 10.16% |
| DSP SMALL CAP FUND,DSP MIDCAP FUND, DSP BUSINESS CYCLE FUND | 9.29% |
| HDFC MID CAP FUND, HDFC INNOVATION FUND | 2.37% |
| MANISH DHANUKA | 0.58% |
| RAHUL DHANUKA | 0.44% |
| MAHENDRA KUMAR DHANUKA HUF (Mahendra Kumar Dhanuka) | 0.43% |
| RAM GOPAL AGARWAL | 0.17% |
| SATYA NARAIN AGARWAL | 0.16% |
| PUSHPA DHANUKA | 0.12% |
| MADHURI DHANUKA | 0.12% |
| UMA DHANUKA | 0.06% |
| MAHENDRA KUMAR DHANUKA | 0.06% |
| HARSH DHANUKA | 0.06% |
| MRIDUL DHANUKA | 0.06% |
| MEGHA DHANUKA | 0.06% |
| AKANGSHA DHANUKA | 0.06% |
| SEEMA DHANUKA | 0.03% |
| SATYANARAIN AGARWAL HUF (Satya Narain Agarwal) | 0% |
| MAMTA DHANUKA | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Dhanuka Agritech against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| COROMANDEL | Coromandel International | 55.6 kCr | 30.87 kCr | -6.80% | -6.50% | 23.17 | 1.8 | - | - |
| UPL | UPL | 51.14 kCr | 49.67 kCr | -3.60% | -5.00% | 29.01 | 1.03 | - | - |
| PIIND | PI Industries | 43.04 kCr | 7.24 kCr | -7.90% | -14.40% | 29.65 | 5.94 | - | - |
| BAYERCROP | Bayer CropScience | 19.83 kCr | 5.71 kCr | +1.60% | -3.00% | 31.32 | 3.18 | - | - |
| RALLIS | Rallis India | 4.73 kCr | 2.91 kCr | -5.50% | +14.10% | 28.42 | 1.62 | - | - |
Comprehensive comparison against sector averages
DHANUKA metrics compared to Fertilizers
| Category | DHANUKA | Fertilizers |
|---|---|---|
| PE | 16.38 | 28.00 |
| PS | 2.16 | 1.92 |
| Growth | 0.5 % | 5.8 % |
Dhanuka Agritech Limited operates as an agro-chemical company in India. The company offers herbicides, insecticides, fungicides, and plant growth regulators in various forms, such as liquid, dust, powder, and granules. It also offers Biological portfolio to control insect, and protects from discase and nutrient uptake. The company was founded in 1980 and is headquartered in Gurugram, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
DHANUKA vs Fertilizers (2021 - 2026)